Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-04-02 Schenkein David P Chief Executive Officer Option exercise +13,000 $0.30 $4K 13,000
2018-04-02 Schenkein David P Chief Executive Officer Sale −1,557 $75.54 $118K 11,443
2018-04-02 Schenkein David P Chief Executive Officer Sale −2,600 $76.40 $199K 8,843
2018-04-02 Schenkein David P Chief Executive Officer Sale −3,340 $77.76 $260K 5,503
2018-04-02 Schenkein David P Chief Executive Officer Sale −3,390 $78.59 $266K 2,113
2018-04-02 Schenkein David P Chief Executive Officer Sale −2,113 $79.49 $168K 0
2018-04-02 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −13,000 78,567
2018-03-28 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −37 1,766
2018-03-28 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −4,100 27,718
2018-03-28 Biller Scott Chief Scientific Officer Option exercise +37 $0.47 $17 53,096
2018-03-28 Biller Scott Chief Scientific Officer Option exercise +4,100 $2.34 $10K 57,196
2018-03-28 Biller Scott Chief Scientific Officer Option exercise · Stock options (right to buy) +37 1,766
2018-03-28 Biller Scott Chief Scientific Officer Option exercise · Stock options (right to buy) +4,100 27,718
2018-03-22 Hoerter Steven L. Chief Commercial Officer Option exercise +2,050 $39.76 $82K 2,050
2018-03-22 Hoerter Steven L. Chief Commercial Officer Sale −2,050 $84.65 $174K 0
2018-03-22 Hoerter Steven L. Chief Commercial Officer Option exercise · Stock option (right to buy) −2,050 70,900
2018-03-19 Foster-Cheek Kaye I Director Option exercise +6,800 $47.33 $322K 9,000
2018-03-19 Foster-Cheek Kaye I Director Sale −6,800 $81.97 $557K 2,200
2018-03-19 Foster-Cheek Kaye I Director Option exercise · Stock option (right to buy) −6,800 0
2018-03-16 Scadden David Director Purchase +200 $83.44 $17K 571

Page 64 of 80 · 1,590 trades